Atlas Trials

The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome

Clinical trial NCT06824324 · COMPLETED

Trial details

NCT number
NCT06824324
Sponsor
Yassir R. Al-khannaq
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myofacial Pain Syndrome
Start date
2024-03-12
Primary completion
2024-11-04
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.